Irinotecan Hydrochloride Trihydrate (CAS Number:136572-09-3)
Irinotecan Hydrochloride Trihydrate belongs to a group of chemotherapy drugs and these are generally known as topoisomerase inhibitors. It It is used for the treatment of colon and rectal cancers. Numerous elements are necessary for the cell division. Irinotecan inhibits the growth of cancer cells by slowing their growth and preventing the development of elements needed for the cell to grow. This medication has side effects such as lowering of platelet count, severe diarrhoea, nausea and vomiting.
Chemical formula: 760 C33H45CLN4O9
Synonyms:[1,4'-Bipiperidine]-1'-carboxylicacid,(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-ylester, monohydrochloride, trihydrate (9CI);[1,4'-Bipiperidine]-1'-carboxylicacid,4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-ylester, monohydrochloride, trihydrate, (S)-;Irinotecanhydrochloridehydrate.
Molecular weight: 677.18
Melting Point: 250-256°C
Assay : 98-99 %
Boiling Point: 873.4°C at 760 mmHg
Flash Point: 482°C
Appearance: Pale yellow to yellow crystalline powder
Package: 5/10/25kg /fibre drums